Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/5856
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSharma, Arun K-
dc.contributor.authorJani, Dewal-
dc.contributor.authorRaghunath, C-
dc.contributor.authorTyagi, Akhilesh K-
dc.date.accessioned2009-08-10T08:28:04Z-
dc.date.available2009-08-10T08:28:04Z-
dc.date.issued2004-04-
dc.identifier.issn0975-0967 (Online); 0972-5849 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/5856-
dc.description274-290en_US
dc.description.abstractRecent advances in molecular and cellular biology have led to the development of technology to engineer plants that are capable of producing a wide variety of products. These include products for pharmaceutical applications, like vaccine antigens, antibodies, antibody-derived fragments and other therapeutic proteins. It is possible to alter endogenous metabolic pathways to obtain new products, like plastics, or to confer novel traits, such as improved nutritional value.en_US
dc.language.isoen_USen_US
dc.publisherCSIRen_US
dc.relation.ispartofseriesInt.Cl.7 A 01 N 63/00; A 61 K 35/74, 35/76, 38/00, 39/02, 39/12; C 12 N 15/00en_US
dc.sourceIJBT Vol.3(2) [April 2004]en_US
dc.subjectantibodyen_US
dc.subjectantigenen_US
dc.subjectbio-degradable plasticsen_US
dc.subjectbioreactorsen_US
dc.subjectnutritionen_US
dc.subjectplantibodyen_US
dc.subjecttransgenic plantsen_US
dc.titleTransgenic plants as bioreactorsen_US
dc.typeArticleen_US
Appears in Collections:IJBT Vol.03(2) [April 2004]

Files in This Item:
File Description SizeFormat 
IJBT 3(2) 274-290.pdf181.42 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.